These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1105111)

  • 1. Plasma phenytoin levels produced by various phenytoin preparations.
    Sansom LN; O'Reilly WJ; Wiseman CW; Stern LM; Derham J
    Med J Aust; 1975 Oct; 2(15):593-5. PubMed ID: 1105111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dissolution rates and bioavailability of phenytoin preparations (author's transl)].
    Brandau R; Wehnert HU
    Arzneimittelforschung; 1979; 29(3):552-5. PubMed ID: 582744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study of phenytoin availability from pharmaceutical preparations].
    Leucuţa SE; Almaşu I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1986; 31(4):273-82. PubMed ID: 2951832
    [No Abstract]   [Full Text] [Related]  

  • 4. Bioavailability of phenytoin from various pharmaceutical preparations in children.
    Manson JI; Beal SM; Magarey A; Pollard AC; O'Reilly WJ; Sansom LN
    Med J Aust; 1975 Oct; 2(15):590-2. PubMed ID: 1196223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma level studies on different brands of sodium diphenylhydantoin (DPH) and primidone.
    Borst SI; Lockwood CH
    Int J Clin Pharmacol Biopharm; 1975 Oct; 12(3):309-14. PubMed ID: 1242131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption and metabolism of phenytoin from tablets and capsules.
    Smith TC; Kinkel A
    Clin Pharmacol Ther; 1976 Dec; 20(6):738-42. PubMed ID: 791565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of three formulations of diphenylhydantoin in the dog.
    Overduin LM; van Gogh H; Mol JA; van Nes JJ
    Res Vet Sci; 1989 Mar; 46(2):271-3. PubMed ID: 2704892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting the bioavailability of phenytoin.
    Neuvonen PJ; Pentikäinen PJ; Elfving SM
    Int J Clin Pharmacol Biopharm; 1977 Feb; 15(2):84-9. PubMed ID: 577918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of formulation on dissolution and bioavailability of phenytoin tablets.
    Chakrabarti S; Belpaire F; Moerman E
    Pharmazie; 1980; 35(10):627-9. PubMed ID: 7454745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bio-availability and dissolution of three phenytoin preparations for children.
    Hodges S; Forsythe WI; Gillies D; Remington H; Cawood A
    Dev Med Child Neurol; 1986 Dec; 28(6):708-12. PubMed ID: 3817309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bio-availability of phenytoin free-acid serum level determinations whilst using a lactose-based tablet-preparation (author's transl)].
    Fritsch G; Haidvogl M; Füger G; Urban C
    Monatsschr Kinderheilkd; 1980 Oct; 128(10):648-50. PubMed ID: 6107823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of phenytoin sodium capsules available in Thailand. Part II: In vivo study.
    Suthisisang C; Payakachat N; Chulavatnatol S; Towanabut S
    J Med Assoc Thai; 1998 Jan; 81(1):64-70. PubMed ID: 9470324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability study of a new amoxicillin tablet designed for several modes of oral administration.
    Cortvriendt WR; Verschoor JS; Hespe W
    Arzneimittelforschung; 1987 Aug; 37(8):977-9. PubMed ID: 3675699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
    Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phenytoin pharmacokinetics as a function of the preparation: capsules, commercial tablets and experimental tablets].
    Almaşu I; Leucuţa SE
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1986; 31(4):283-93. PubMed ID: 2951833
    [No Abstract]   [Full Text] [Related]  

  • 17. Bioavailability of phenytoin. A comparison of two preparations.
    Stewart MJ; Ballinger BR; Devlin EJ; Miller AY; Ramsay AC
    Eur J Clin Pharmacol; 1975 Dec; 9(2-3):209-12. PubMed ID: 1243984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability of phenytoin sodium capsules available in Thailand. Part I: In vitro study.
    Suthisisang C; Payakachat N
    J Med Assoc Thai; 1998 Jan; 81(1):58-63. PubMed ID: 9470323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability of four brands of phenytoin tablets.
    Pentikäinen PJ; Neuvonen PJ; Elfving SM
    Eur J Clin Pharmacol; 1975 Dec; 9(2-3):213-8. PubMed ID: 1243985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmaceutical and biological availability of commercial preparations of furosemide.
    Stüber W; Mutschler E; Steinbach D
    Arzneimittelforschung; 1982; 32(6):693-7. PubMed ID: 6889429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.